000			01922 a2200553 4500
005			20250513212220.0
264		0	_c20000822
008			200008s 0 0 eng d
022			_a0269-9370
024	7		_a10.1097/00002030-200005050-00008 _2doi
040			_aNLM _beng _cNLM
100	1		_aO'Brien, T R
245	0	0	_aEffect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapy. _h[electronic resource]
260			_bAIDS (London, England) _cMay 2000
300			_a821-6 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdult
650	0	4	_aAlleles
650	0	4	_aAnti-HIV Agents _xtherapeutic use
650	0	4	_aChemokine CXCL12
650	0	4	_aChemokines, CXC _xgenetics
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aGene Frequency
650	0	4	_aHIV Infections _xdrug therapy
650	0	4	_aHIV-1 _xgenetics
650	0	4	_aHumans
650	0	4	_aIndinavir _xtherapeutic use
650	0	4	_aLamivudine _xtherapeutic use
650	0	4	_aLinkage Disequilibrium
650	0	4	_aMale
650	0	4	_aPolymorphism, Genetic _xgenetics
650	0	4	_aRNA, Viral _xblood
650	0	4	_aReceptors, CCR2
650	0	4	_aReceptors, CCR5 _xgenetics
650	0	4	_aReceptors, Chemokine _xgenetics
650	0	4	_aReceptors, Cytokine _xgenetics
650	0	4	_aReverse Transcriptase Inhibitors _xtherapeutic use
650	0	4	_aTreatment Outcome
650	0	4	_aZidovudine _xtherapeutic use
700	1		_aMcDermott, D H
700	1		_aIoannidis, J P
700	1		_aCarrington, M
700	1		_aMurphy, P M
700	1		_aHavlir, D V
700	1		_aRichman, D D
773	0		_tAIDS (London, England) _gvol. 14 _gno. 7 _gp. 821-6
856	4	0	_uhttps://doi.org/10.1097/00002030-200005050-00008 _zAvailable from publisher's website
999			_c10790962 _d10790962